APA (7th ed.) Citation

S, T., A, D., M, M., L, M., J, M., M, K., . . . S, v. K. (2026). Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-73189-8

Chicago Style (17th ed.) Citation

S, Tishina, et al. "Oncogenic KRAS-driven Type I Interferon Signalling Primes Pancreatic Cancer for Necroptosis." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-73189-8.

MLA (9th ed.) Citation

S, Tishina, et al. "Oncogenic KRAS-driven Type I Interferon Signalling Primes Pancreatic Cancer for Necroptosis." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-73189-8.